Shearman Reps Quest Diagnostics In $344M Celera Buy
Quest Diagnostics Inc. said Friday it would shell out about $344 million to pick up fellow diagnostic testing company Celera Corp. in an effort to strengthen its hold on the gene-based...To view the full article, register now.
Already a subscriber? Click here to view full article